SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-188339
Filing Date
2015-05-14
Accepted
2015-05-14 17:29:51
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d911446d10q.htm 10-Q 638474
2 EX-31.1 d911446dex311.htm EX-31.1 8665
3 EX-31.2 d911446dex312.htm EX-31.2 8628
4 EX-32.1 d911446dex321.htm EX-32.1 5354
  Complete submission text file 0001193125-15-188339.txt   4631825

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT itek-20150331.xml EX-101.INS 496679
6 XBRL TAXONOMY EXTENSION SCHEMA itek-20150331.xsd EX-101.SCH 41461
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itek-20150331_cal.xml EX-101.CAL 46775
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itek-20150331_def.xml EX-101.DEF 207585
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE itek-20150331_lab.xml EX-101.LAB 354609
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itek-20150331_pre.xml EX-101.PRE 276116
Mailing Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421
Business Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421 781-676-2100
INOTEK PHARMACEUTICALS CORP (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 15864185
SIC: 2834 Pharmaceutical Preparations